Protein– tag –
-
Meatly Secures $14M Series A to Build Europe’s Largest Cultivated Meat Facility in London
Green Queen Media UK Overview British food tech firm Meatly has raised £10 million ($14.1 million) in Series A funding to construct a 20,000-liter cultivated meat pilot plant in London, set to become Europe's largest. The company, which ... -
Veritas In Silico Advances mRNA-Targeted Small Molecule Drug Discovery with AI Platform ‘aibVIS,’ Bolstering European Collaborations
Investing.com (Fisco提供) Japan Overview Japanese biotech Veritas In Silico (VIS) is spearheading mRNA-targeted small molecule drug discovery using its proprietary AI platform, "aibVIS." This platform integrates in silico RNA structure a... -
Alteogen Secures Domestic Approval for Aflibercept Biosimilar ‘Eygenpiju’ in South Korea, Accelerating Global Reach
Daum South Korea Overview South Korean biopharmaceutical company Alteogen announced domestic market approval from the Ministry of Food and Drug Safety (MFDS) for 'Eygenpiju' (ALT-L9), its aflibercept biosimilar. This approval follows Eur... -
Avidity Biosciences Leads Muscle Disease Therapy with Antibody-Oligonucleotide Conjugates (AOCs): DM1 HARBINGER™ Trial Advances to Phase 3
Bitget Global Overview Avidity Biosciences is a leading company in Antibody-Oligonucleotide Conjugates (AOCs), developing novel RNA therapeutics for muscle diseases. Its lead candidate, delpacibart etedesiran (AOC 1001), is progressing i... -
Precision Peptide Company (BPC) Pioneers Advanced Peptide Manufacturing with Continuous Flow Synthesis and AI Integration to Meet GLP-1 Demand
Bitget アイルランド Overview Precision Peptide Company Inc. (BPC) is emerging as a critical CDMO partner for GLP-1 agonists, oncology vaccines, and targeted radiopharmaceuticals. Their proprietary "Flow-Peptide" continuous flow synthesis... -
The Modern CDMO: A Strategic Blueprint for Pharmaceutical Leaders in a Complex Era
Agnopharma Global Overview This guide outlines the evolution of CDMOs from traditional CMOs, emphasizing their indispensable role in contemporary drug development. Modern CDMOs offer integrated solutions from process development to comme... -
Pharmaceutical Manufacturing Realignments Create Expansion Opportunities for CDMOs: GSK, BMS, Sanofi Divest Facilities
Pharmaceutical Technology USA Overview A significant reconfiguration is underway in the pharmaceutical manufacturing sector, with major CDMOs acquiring production facilities from pharmaceutical companies. Samsung Biologics, Rois, and Adr... -
OpenBind Launches First Open Dataset and AI Model to Enhance Drug-Target Interaction Prediction, Applied to EV-A71 Virus
University of Oxford UK Overview Researchers at the University of Oxford, as part of the OpenBind consortium, have released the first open dataset and predictive AI model specifically designed for drug discovery. This dataset comprises d... -
Isomorphic Labs Secures $2.1 Billion for AI Drug Discovery, Scaling AlphaFold-Driven Platform for Diverse Modalities
Pharmaceutical Technology UK Overview Isomorphic Labs, an Alphabet-backed AI drug discovery company, has closed a monumental $2.1 billion Series B funding round to accelerate its AI-driven drug development efforts. The investment will pr... -
KRIBB Develops Ultra-Precision Nanopore Sensor for Atomic-Level Analysis of Protein-Drug Binding
電子新聞 (韓国) South Korea Overview A KRIBB team developed an ultra-precision nanopore sensor capable of observing and analyzing protein-drug binding at an atomic level. This sensor detects subtle electrical signal changes as proteins p...
